NCT00600769View on ClinicalTrials.gov

Clarithromycin for the Treatment of Infections Caused by Nontuberculous Mycobacteria (NTM)

PHASE4CompletedINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

January 31, 1991

Primary Completion Date

November 30, 2006

Study Completion Date

May 18, 2017

Conditions
Nontuberculous MycobacteriaMycobacterium Avium Complex
Interventions
DRUG

Clarithromycin

Dosage dependent on clinical factors such as age, weight and patient-specific health status

Trial Locations (1)

75708

The University of Texas Health Science Center at Tyler, Tyler

Sponsors

Collaborators (1)

Abbott
All Listed Sponsors
collaborator

Abbott

INDUSTRY

lead

The University of Texas Health Science Center at Tyler

OTHER